NTT Research Inc, a division of Japanese telecoms company NTT (Tokyo:9432), announced on Wednesday a collaboration with researchers at Harvard to develop a model of the human heart.
NTT Research's Medical & Health Informatics (MEI) Lab has entered into a three-year joint research agreement with the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) to engineer a model of the human heart, elucidate fundamental laws of muscular pumps and apply lessons learned to a cardiovascular (CV) bio digital twin model.
The joint research is expected to to elucidate structure-function relationships of the heart that may have been overlooked in the canon of CV physiology, NTT Research said.
CSL reveals top-line outcome from Phase three AEGIS-II trial of CSL112
AstraZeneca invests USD300m to expand US manufacturing for cell therapy
Innovent Biologics announces CFO transition
Cardio Diagnostics appoints Dr Vimal Ramjee as Strategic Advisor
Acticor Biotech reports positive ACTIMIS clinical study results in Lancet Neurology Journal
Sarepta Therapeutics commences Phase 3 clinical study of SRP-9003 for LGMD2E